Learning Objectives
At the conclusion of this activity, participants will be able to:
-
Define tubular kidney biomarkers and describe their relevance in people with HIV.
-
Summarize key evidence linking urine and plasma tubular biomarkers with tenofovir-associated nephrotoxicity and rapid kidney function decline in HIV.
-
Apply tubular biomarker data to patient cases to guide antiretroviral therapy decisions and kidney monitoring strategies.
Faculty Presenter:
Dhakrit (Jesse) Rungkitwattanakul, PharmD BCPS FNKF FASN
Associate Professor | Nephrology Pharmacist
Howard University College of Pharmacy
2300 4th St NW | Washington, D.C. 20059
Email: dhakrit.rungkitwatt@howard.edu